Anne H. Blaes
Expertise in
10
conditions

Dr. Anne H. Blaes

Oncology
909 Fulton Street Southeast, 
Minneapolis, MN 
Accepting New Patients
Offers Telehealth
Expertise in
10
conditions
909 Fulton Street Southeast, 
Minneapolis, MN 

Overview

Anne Blaes is an Oncologist practicing medicine in Minneapolis, Minnesota.

Dr. Blaes is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Adult Soft Tissue Sarcoma.

Dr. Blaes is board certified in Medical Oncology: American Board Of Internal Medicine, 2009 and Internal Medicine: American Board Of Internal Medicine, 2005. She is actively involved in clinical research, co-authoring 224 peer reviewed articles and participating in 1 clinical trial. Dr. Blaes is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in MN

Board Certifications

Medical Oncology: American Board Of Internal Medicine, 2009
Internal Medicine: American Board Of Internal Medicine, 2005

Fellowships

University of Minnesota-Hematology and Oncology, Hematology/Oncology - 2009

Hospital Affiliations

Fairview Lakes Health Services
M Health Fairview University Of Mn Medical Center
M Health Fairview Southdale Hospital
M Health Fairview Ridges Hospital
M Health Fairview St John's Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Primewest Health System
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Sanford Health
  • HMO
  • PPO
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

M Health Fairview Masonic Cancer Clinic
909 Fulton Street Southeast, Minneapolis, MN 55455

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016
A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016
Enrollment Status: Completed
Publish Date: January 20, 2026
Intervention Type: Drug
Study Drugs: Palbociclib, Tamoxifen
Study Phase: Phase 2

223 Total Publications

Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.
Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement.
Journal: Cardio-oncology (London, England)
Published: July 10, 2026
Similar Doctors
Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

M Health Fairview Masonic Cancer Clinic

909 Fulton Street Southeast, 
Minneapolis, MN 
 (0.1 miles away)
612-676-4200
Languages Spoken:
English, French, Greek
See accepted insurances
Accepting New Patients
Offers Telehealth

Emmanuel Antonarakis is an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Antonarakis is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, PIK3CA-Related Overgrowth Spectrum, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Antonarakis is board certified in Medical Oncology: American Board Of Internal Medicine, 2009. Dr. Antonarakis is currently accepting new patients.

Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

M Health Fairview Masonic Cancer Clinic

909 Fulton Street Southeast, 
Minneapolis, MN 
 (0.1 miles away)
612-676-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Keith Skubitz is an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Skubitz is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Bone Tumor, Liposarcoma, Alveolar Soft Part Sarcoma, and Splenectomy. Dr. Skubitz is board certified in Medical Oncology: American Board Of Internal Medicine, 1985 and Internal Medicine: American Board Of Internal Medicine, 1979. Dr. Skubitz is currently accepting new patients.

Expertise in
9
conditions
Dr. Mukta Arora
Hematology | Oncology
Expertise in
9
conditions
Dr. Mukta Arora
Hematology | Oncology
Referral may be required

Fairview Pharmacy Services LLC

516 Delaware St SE, 
Minneapolis, MN 
 (0.1 miles away)
612-273-2800
Languages Spoken:
English
See accepted insurances

Mukta Arora is a Hematologist and an Oncologist practicing medicine in Minneapolis, Minnesota. Dr. Arora is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Anne H. Blaes

How do I make an appointment with Dr. Anne H. Blaes?

You can book an appointment with Dr. Anne H. Blaes by calling their office at 612-676-4200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Anne H. Blaes a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Anne H. Blaes is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Anne H. Blaes specialize in?

While Dr. Anne H. Blaes is a Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Anne H. Blaes participate in research or clinical trials?

Yes. Dr. Anne H. Blaes has published 223 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Anne H. Blaes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Anne H. Blaes accept my insurance?

Dr. Anne H. Blaes accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 612-676-4200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Blaes's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 35 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile